ATI RN
ATI Pharmacology 2016 Practice Exam A Questions
Question 1 of 5
A healthcare professional is preparing to administer a dose of Hydromorphone IV to a client. Which of the following actions should the healthcare professional take?
Correct Answer: A
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 2 of 5
A healthcare provider is reviewing the health care record of a client who reports urinary incontinence and asks about a prescription for Oxybutynin. The healthcare provider should recognize that Oxybutynin is contraindicated in the presence of which of the following conditions?
Correct Answer: D
Rationale: Oxybutynin is an anticholinergic medication that can increase intraocular pressure. It is contraindicated in clients with glaucoma due to the potential to worsen the condition by further elevating intraocular pressure, leading to harm. Therefore, choosing option D, Glaucoma, as the correct answer is essential for the client's safety and to prevent exacerbation of their eye condition.
Question 3 of 5
A client has a new prescription for Zolpidem. Which of the following instructions should the nurse include?
Correct Answer: A
Rationale: Zolpidem is classified under Pregnancy Risk Category C. It is essential for the client to inform the provider if she plans to become pregnant as Zolpidem use during pregnancy may pose risks to the fetus. This precaution allows for appropriate assessment and possible adjustments to the treatment plan to ensure the safety of both the client and the developing baby.
Question 4 of 5
A client reports taking Phenylephrine nasal drops for the past 10 days for Sinusitis. The nurse should assess the client for which of the following adverse effects of this medication?
Correct Answer: B
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 5 of 5
A healthcare professional is monitoring a client who is receiving spironolactone. Which of the following findings should the professional report to the provider?
Correct Answer: C
Rationale: A serum potassium level of 5.2 mEq/L indicates hyperkalemia. Spironolactone is a potassium-sparing diuretic that can cause potassium retention. Hyperkalemia is a serious condition that can lead to cardiac dysrhythmias. The healthcare professional should withhold the medication and promptly notify the provider to prevent potential complications.